These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 30182910)
1. The global elimination of hepatitis C? Sonderup MW S Afr Med J; 2018 Aug; 108(8b):31-34. PubMed ID: 30182910 [TBL] [Abstract][Full Text] [Related]
2. The phases of hepatitis C elimination: achieving WHO elimination targets. Pedrana A; Munari S; Stoové M; Doyle J; Hellard M Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):6-8. PubMed ID: 33308435 [No Abstract] [Full Text] [Related]
3. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30. Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061 [TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals. Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426 [TBL] [Abstract][Full Text] [Related]
5. Elimination of Hepatitis C Virus in Australia: Laying the Foundation. Dore GJ; Hajarizadeh B Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255 [TBL] [Abstract][Full Text] [Related]
6. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective. Jonas MC; Loftus B; Horberg MA Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267 [TBL] [Abstract][Full Text] [Related]
8. Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs. Martinello M; Dore GJ; Matthews GV; Grebely J Infect Dis Clin North Am; 2018 Jun; 32(2):371-393. PubMed ID: 29778261 [TBL] [Abstract][Full Text] [Related]
9. Innovations in Hepatitis C Screening and Treatment. Patel AA; Bui A; Prohl E; Bhattacharya D; Wang S; Branch AD; Perumalswami PV Hepatol Commun; 2021 Mar; 5(3):371-386. PubMed ID: 33681673 [TBL] [Abstract][Full Text] [Related]
10. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination. Naggie S; Wyles D J Infect Dis; 2020 Nov; 222(Suppl 9):S741-S744. PubMed ID: 33245351 [No Abstract] [Full Text] [Related]
11. Hepatitis C Virus Diagnosis and the Holy Grail. Applegate TL; Fajardo E; Sacks JA Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264 [TBL] [Abstract][Full Text] [Related]
12. Eliminating hepatitis C. Burki T Lancet Infect Dis; 2019 Mar; 19(3):246-247. PubMed ID: 30833063 [No Abstract] [Full Text] [Related]
13. Hepatitis elimination by 2030: Progress and challenges. Waheed Y; Siddiq M; Jamil Z; Najmi MH World J Gastroenterol; 2018 Nov; 24(44):4959-4961. PubMed ID: 30510370 [TBL] [Abstract][Full Text] [Related]
14. Eliminating hepatitis from the Eastern Mediterranean Region. Fikri M East Mediterr Health J; 2017 Aug; 23(7):459-460. PubMed ID: 28853128 [No Abstract] [Full Text] [Related]
15. MEDICINE. Global control of hepatitis C virus. Cox AL Science; 2015 Aug; 349(6250):790-1. PubMed ID: 26293940 [No Abstract] [Full Text] [Related]
16. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe. Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946 [TBL] [Abstract][Full Text] [Related]
18. Eradication of hepatitis C infection: the importance of targeting people who inject drugs. Hellard M; Doyle JS; Sacks-Davis R; Thompson AJ; McBryde E Hepatology; 2014 Feb; 59(2):366-9. PubMed ID: 23873507 [No Abstract] [Full Text] [Related]
19. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. European Union HCV Collaborators Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696 [TBL] [Abstract][Full Text] [Related]
20. A model of the economic benefits of global hepatitis C elimination: an investment case. Scott N; Kuschel C; Pedrana A; Schroeder S; Howell J; Thompson A; Wilson DP; Hellard M Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):940-947. PubMed ID: 32730785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]